Drug Trial Radar · NCT04516278
A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders
Last checked: Nov 20, 2026Latest source record: Jul 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
197
Actual
Start
Oct 1, 2020
Primary completion
Feb 10, 2021
Study completion Feb 10, 2021
Sponsor
- Lead sponsor
- Outlook Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 18, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will evaluate the safety of ophthalmic bevacizumab in subjects diagnosed with a retinal condition that would benefit from treatment with intravitreal injection of bevacizumab, including: exudative age-related macular degeneration, diabetic macular edema, or branch retinal vein occlusion.
Conditions
- Age-related Macular Degeneration
- Neovascular Age-related Macular Degeneration
- Wet Macular Degeneration
- BRVO - Branch Retinal Vein Occlusion
- Diabetic Macular Edema
Interventions
bevacizumabBiological
1.25 mg, intravitreal injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse EventsTime frame: 3 months
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Clinical Site
Tucson, Arizona
Clinical Site
Beverly Hills, California
Clinical Site
Glendale, California
Clinical Site
Long Beach, California
Clinical Site
Palm Desert, California
Clinical Site
Poway, California
Clinical Site
Clearwater, Florida
Clinical Site
Winter Haven, Florida
Clinical Site
Oak Forest, Illinois
Clinical Site
Springfield, Illinois
Clinical Site
Hagerstown, Maryland
Clinical Site
Albuquerque, New Mexico
Clinical Site
Chambersburg, Pennsylvania
Clinical Site
Rapid City, South Dakota
Clinical Site
Germantown, Tennessee
Clinical Site
Abilene, Texas
Clinical Site
Arlington, Texas
Clinical Site
McAllen, Texas
Clinical Site
San Antonio, Texas
Clinical Site
Willow Park, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.